The reason for this can be attributed to several factors: Increased Demand: Medications containing semaglutide and tirzepatide are currently listed on the FDA shortage list
Li L, He D, Guo Q, Zhang Z, Ru D, Wang L, et al
But the bet hasnt seemed to pay off yet
While Ozempic is a popular brand of GLP-1 receptor agonist used for weight loss and diabetes management, GLP-1 itself refers to a class of medications with similar effects
DSIPs regulatory influence on hormonal balance and stress pathways positions it as a promising option in peptide therapy to address sleep disturbances and associated conditions, improving quality of life and overall well-being
The survey findings also estimate that about two million Canadian adults are not taking the medications but would like to